public scientific scrutiny Archives - Pharma Marketing Network

Home Tags Public scientific scrutiny

Advisory Committees as Brand Moments: Preparing for Public Scientific Scrutiny

Donna Pacheco - May 12, 2026

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Advisory Committees as Brand Moments: Preparing for Public Scientific Scrutiny

May 12, 2026

Pharmaceutical marketing professional reviewing real-time clinical data dashboards and digital campaign analytics in a modern healthcare workspace.

Real-Time Evidence, Real-Time Marketing: Why Static Campaigns Are Becoming a Risk

May 12, 2026

Patient comparing branded, generic, and compounded medications in a modern pharmaceutical setting representing healthcare decision-making and FDA oversight.

Compounded vs. Branded vs. Generic: The New Battle for Patient Understanding

May 11, 2026